Recent Posts

Can Skolkovo Replicate MIT?

斯科尔科沃科技学院能够复制麻省理工学院的模式吗?Loren Graham, an MIT historian of science, shows that Russian inventors have been ingenious in developing scientific and technical ideas, but failed to benefit from them. Now, however, they have yet another chance. Can Skolkovo replicate the success of MIT? Read more to find out why it can not.

Read More »

CIV August 2016 Updates

Dear friend, I’m writing to share with you our top five latest updates published by CIV. (1) Can Venture Make or Break Universities — access papers from the Univenture Issue of Coller Venture Review (2) Grants on “City Venture” Research — submission deadline: 30-Sep-2016 (3) Meet CIV in Berlin — see more details and request a ticket to our cocktail and award …

Read More »

Can the EU Bridge its Innovation Gap with the US?

欧盟能够缩小其与美国的创新差距吗?Europe needs innovative ventures, yet it is facing a significant innovation challenge, where good ideas are too rarely turned into new products or services – despite an excellent academic research base, dynamic companies and creative talent.Can the EU catch up? Find the answer in an article by Jean H. A. Gelissen, presenting a newly designed EU Univenture ecosystem, at the University Venture Issue of Coller Venture Review

Read More »

Crafting a Silicon Savannah

精心打造肯尼亚“大草原硅谷” It’s easy to do university venture in the U.S. or Europe. Starting a Univenture drive in Africa is a whole different story... How to build a “Silicon Savannah” in a challenging environment? Read about Univenture in an emerging context in a paper by Wilfred Mworia, published in the new University Venture Issue of  Coller Venture Review

Read More »

TAU Brain Scholar Wins a $50,000 Alzheimer Research Award

特拉维夫大学大脑科学研究者荣膺5万美元阿尔茨海默病研究奖 Prof. Inna Slutsky, head of the Slutsky lab at Tel Aviv University, is the first Israeli researcher to win a $50,000 MetLife Foundation Award for Alzheimer Research. The lab is part of the Sagol School of Neuroscience - an interdisciplinary framework for brain research, integrating researchers and labs from the schools of Medicine, Life Sciences, Social Sciences, Exact Sciences and Engineering. Neuroscience was so far majorly abandoned by big pharma companies, and the Deep Innovation issue of CVR discusses new initiatives and innovation models set to bring back industry, government and academia into this complex game.

Read More »